Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
67.15 USD | +0.98% | +4.06% | +26.01% |
Financials (USD)
Sales 2024 * | 2.48B | Sales 2025 * | 2.65B | Capitalization | 9.07B |
---|---|---|---|---|---|
Net income 2024 * | 227M | Net income 2025 * | 382M | EV / Sales 2024 * | 3.56 x |
Net cash position 2024 * | 262M | Net cash position 2025 * | 748M | EV / Sales 2025 * | 3.14 x |
P/E ratio 2024 * |
40.4
x | P/E ratio 2025 * |
24
x | Employees | 5,000 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 82.75% |
Latest transcript on Globus Medical, Inc.
1 day | +0.98% | ||
1 week | +4.06% | ||
Current month | +34.87% | ||
1 month | +31.02% | ||
3 months | +21.52% | ||
6 months | +46.04% | ||
Current year | +26.01% |
Managers | Title | Age | Since |
---|---|---|---|
Daniel Scavilla
CEO | Chief Executive Officer | 59 | 15-05-03 |
David Davidar
FOU | Founder | 58 | 03-02-28 |
David Paul
FOU | Founder | 57 | 03-02-28 |
Members of the board | Title | Age | Since |
---|---|---|---|
Stephen Zarrilli
BRD | Director/Board Member | 62 | 19-04-30 |
Rob Douglas
BRD | Director/Board Member | 64 | 19-12-10 |
James Tobin
BRD | Director/Board Member | 79 | 15-08-27 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
1.01% | 2 M€ | 0.00% | ||
0.99% | 144 M€ | +2.20% | - | |
0.74% | 14 M€ | -3.15% | ||
0.44% | 8 M€ | 0.00% |
Date | Price | Change | Volume |
---|---|---|---|
24-05-22 | 67.15 | +0.98% | 959,877 |
24-05-21 | 66.5 | +0.36% | 870,799 |
24-05-20 | 66.26 | +2.89% | 1,094,834 |
24-05-17 | 64.4 | +0.70% | 733,075 |
24-05-16 | 63.95 | -0.90% | 853,680 |
Delayed Quote Nyse, May 22, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+26.01% | 9.07B | |
-4.77% | 182B | |
+4.10% | 114B | |
-3.85% | 67.76B | |
+5.19% | 51.91B | |
+5.54% | 43.23B | |
+6.07% | 41.07B | |
+23.81% | 32.07B | |
+15.86% | 25B | |
-5.06% | 24.35B |
- Stock Market
- Equities
- GMED Stock